JUN 12, 2020 8:12 AM PDT

Reserach on APOBEC3A opens the way for new treatment targets

New research identifies how a protein, APOBEC3A, triggers genetic changes that result in various cancers. This expansion of the understanding that APOBEC3A plays in tumor cells could lead to more effective targeted anti-cancer treatments. 

Photo: Pixabay

The research, entitled, "Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots," was led by scientists from the University of California, Irvine.  Senior investigator Remi Buisson, PhD, is an assistant professor in the Department of Biological Chemistry at the UCI School of Medicine. Buisson commented: 

"Targeting cancer cells with high levels of APOBEC3A protein activities and disrupting, at the same time, the DNA damage response necessary to repair damages caused by APOBEC3A, could be key to more effective cancer therapies. However, to exploit the vulnerability of the cancer cells, it is critical to first quantitatively measure the protein's activity in tumors."

In order to quantify that activity, the researchers developed an assay using hotspot RNA mutations to measure the RNA-editing activity of APOBEC3A in cancer cells. To do so, they utilized droplet digital PCR. 

The implications of this study, which was published in Nature Communications, are significant, say the researchers.

"Our study presents a new strategy to follow the dysregulation of APOBEC3A in tumors, providing opportunities to investigate the role of APOBEC3A in tumor evolution and to target the APOBEC3A-induced vulnerability in therapy," said Buisson. "We anticipate that the RNA mutation-based APOBEC3A assay will significantly advance our understanding of the function of the protein in tumorigenesis and allow us to more effectively exploit the vulnerabilities it creates in cancer therapy."

Sources: Nature Communications, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 02, 2020
Immunology
A Shingles Vaccine for Cancer Patients
DEC 02, 2020
A Shingles Vaccine for Cancer Patients
Receiving a vaccine (usually in the form of an inactivated pathogen) triggers an immune response without the symptoms of ...
NOV 30, 2020
Cancer
Using deep learning to identify breast cancer biomarkers in mammograms
NOV 30, 2020
Using deep learning to identify breast cancer biomarkers in mammograms
A team from Massachusetts General Hospital (MGH) has developed a deep learning model capable of predicting a patient&rsq ...
DEC 16, 2020
Clinical & Molecular DX
Gene Marker PACS a Punch for Cervical Cancer Treatments
DEC 16, 2020
Gene Marker PACS a Punch for Cervical Cancer Treatments
In cervical cancer, mutations in healthy cells cause cells to grow and multiply uncontrollably, invading surrounding tis ...
DEC 24, 2020
Cancer
Seven DNA fingerprints determine genetic predisposition for cancer
DEC 24, 2020
Seven DNA fingerprints determine genetic predisposition for cancer
New research published in Science Advances is attempting to change the way that we think about cancer. The research ...
JAN 08, 2021
Chemistry & Physics
Detecting tumors from the shear waves emitted by song
JAN 08, 2021
Detecting tumors from the shear waves emitted by song
Will a singing test be the way the doctors of the future monitor thyroid health? According to a collaboration of researc ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
Loading Comments...